Flash Player Not Installed.
To Install, click here.
To Install, click here.
- Levulan® Kerastick®
Levulan® Kerastick®Levulan® Kerastick® plus blue light illumination using the BLU-U® blue light photodynamic therapy illuminator is indicated for the treatment of minimally to moderately thick actinic keratoses (Grade 1 or 2) of the face or scalp.
Learn More >> - BLU-U®
BLU-U®The BLU-U is a unique blue light that can kill the P. acnes bacteria in your skin.
Learn More >> - ClindaReachTM
ClindaReachTMClindaReach is indicated for the topical treatment of acne vulgaris and is only available by prescription.
Learn More >>
News
July 18, 2008
DUSA Announces Update on Nicomide® Status
June 19, 2008
DUSA Pharmaceuticals to Present at the Jefferies 2nd Annual Healthcare Conference on June 26
May 16, 2008
DUSA Files Form S-3 Shelf Registration Statement
Welcome
DUSA Pharmaceuticals, Inc.® is an integrated dermatology pharmaceutical company focused primarily on the development and marketing of its Levulan Photodynamic Therapy (PDT) technology platform, and complementary dermatology products.
DUSA's other dermatology products include ClindaReach and Nicomide, resulting from its recent merger with Sirius Laboratories, Inc. These products target patients with acne. DUSA is also developing certain internal indications of Levulan PDT. DUSA is based in Wilmington, MA.
